These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 8816912

  • 1. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L, Dimri GP, Campisi J, Chen KY.
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [Abstract] [Full Text] [Related]

  • 2. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H, Geymayer S, Haidweger E.
    J Mol Biol; 1999 Nov 12; 293(5):1005-15. PubMed ID: 10547281
    [Abstract] [Full Text] [Related]

  • 3. The bidirectionally transcribed dihydrofolate reductase and rep-3a promoters are growth regulated by distinct mechanisms.
    Schilling LJ, Farnham PJ.
    Cell Growth Differ; 1995 May 12; 6(5):541-8. PubMed ID: 7647037
    [Abstract] [Full Text] [Related]

  • 4. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN.
    Oncogene; 1997 Jul 10; 15(2):143-57. PubMed ID: 9244350
    [Abstract] [Full Text] [Related]

  • 5. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
    Strom DK, Cleveland JL, Chellappan S, Nip J, Hiebert SW.
    Cell Growth Differ; 1998 Jan 10; 9(1):59-69. PubMed ID: 9438389
    [Abstract] [Full Text] [Related]

  • 6. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
    Itoh A, Levinson SF, Morita T, Kourembanas S, Brody JS, Mitsialis SA.
    Cell Mol Biol Res; 1995 Jan 10; 41(3):147-54. PubMed ID: 8589754
    [Abstract] [Full Text] [Related]

  • 7. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE.
    Exp Cell Res; 1999 Dec 15; 253(2):561-72. PubMed ID: 10585280
    [Abstract] [Full Text] [Related]

  • 8. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ, Schaley JE, Feeney G, Hearing P.
    Oncogene; 2001 Apr 05; 20(15):1882-91. PubMed ID: 11313936
    [Abstract] [Full Text] [Related]

  • 9. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC, Pützer B, Schwabe G, Gnauck HK, Schulte Holthausen H.
    Cell Mol Biol Res; 1993 Apr 05; 39(8):705-16. PubMed ID: 7951410
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M.
    Oncogene; 1999 Mar 18; 18(11):2003-14. PubMed ID: 10208422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J, Illenye S, Chang YC, Mitsui Y, Heintz NH.
    Oncogene; 1999 Jan 21; 18(3):593-605. PubMed ID: 9989809
    [Abstract] [Full Text] [Related]

  • 13. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K, Nakajima Y, Eto K, Ikeda MA.
    Oncogene; 2003 Oct 23; 22(48):7632-41. PubMed ID: 14576826
    [Abstract] [Full Text] [Related]

  • 14. Transcription from TATA-less promoters: dihydrofolate reductase as a model.
    Azizkhan JC, Jensen DE, Pierce AJ, Wade M.
    Crit Rev Eukaryot Gene Expr; 1993 Oct 23; 3(4):229-54. PubMed ID: 8286846
    [Abstract] [Full Text] [Related]

  • 15. Regulation of E2F-1 gene expression in avian cells.
    Espanel X, Le Cam L, North S, Sardet C, Brun G, Gillet G.
    Oncogene; 1998 Aug 06; 17(5):585-94. PubMed ID: 9704924
    [Abstract] [Full Text] [Related]

  • 16. Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter.
    Noé V, Alemany C, Chasin LA, Ciudad CJ.
    Oncogene; 1998 Apr 16; 16(15):1931-8. PubMed ID: 9591776
    [Abstract] [Full Text] [Related]

  • 17. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD, Farlie PG, Watson RJ.
    Oncogene; 1996 Sep 05; 13(5):1073-82. PubMed ID: 8806697
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H, Iavarone A, Reeves SA.
    Oncogene; 1998 Mar 26; 16(12):1513-23. PubMed ID: 9569018
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D, Schulze A, Boye B, Jansen-Dürr P.
    Cell Growth Differ; 1997 Jun 26; 8(6):699-710. PubMed ID: 9186003
    [Abstract] [Full Text] [Related]

  • 20. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
    Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Smulson ME.
    Oncogene; 1999 Sep 09; 18(36):5015-23. PubMed ID: 10490838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.